Sign in to continue:

Saturday, March 7th, 2026

Dominari Holdings Inc. (DOMH) 8-K SEC Filing Summary, Company Info & Stock Details (2026)

Dominari Holdings Inc. Announces Key Amendments to 2022 Equity Incentive Plan Following Special Shareholder Meeting

Dominari Holdings Inc. (NASDAQ: DOMH), formerly known as Akido Pharma, Inc., has released a detailed Form 8-K report following a special meeting of shareholders held on March 4, 2026. The meeting addressed significant proposals that could impact the company’s share structure and future employee incentives, with potential implications for investor value and share price.

Key Highlights from the Special Meeting

  • Increase in Shares Reserved for Equity Incentive Plan: Shareholders voted on a proposal to amend Section 4(a) of the Dominari Holdings Inc. 2022 Equity Incentive Plan, increasing the number of shares of common stock reserved for issuance with respect to awards granted under the plan by 10,000,000 shares. This raises the total from 11,720,750 shares to 21,720,750 shares.
  • Clarification on Annual Share Increase: Section 4(b) of the plan was also proposed to be amended to clarify the calculation of annual increases in shares reserved for issuance. Starting January 1, 2027, and continuing through January 1, 2032, the number of shares reserved will automatically increase each January 1st by the lesser of 20% of the total number of shares outstanding or a number to be determined by the Board.
  • Voting Quorum and Results: A quorum representing approximately 43.27% of eligible voting stock was present or represented by proxy. The shares eligible to vote included common stock, Series D Convertible Preferred Stock, and Series D-1 Convertible Preferred Stock, with respective voting powers detailed in the report.
  • Proposal Approval: The amendment proposals, including the equity plan increase and annual increase clarification, were approved by a majority of votes cast.

Implications for Shareholders and Potential Share Price Movement

  • Potential Dilution: The increase in shares reserved for the equity incentive plan may lead to future dilution for existing shareholders if new options or awards are exercised, potentially affecting share value.
  • Employee and Executive Incentives: A larger reserve of shares for awards could help the company attract and retain talent, but may also increase the number of outstanding shares, impacting earnings per share calculations.
  • Price Sensitivity: The approval of such a large increase in reserved shares is a material event that investors should monitor, as it may signal strategic moves by management, expansion plans, or shifts in compensation policy.
  • No Pre-commencement Communications or Tender Offers: The filing confirms that the company did not engage in written communications pursuant to Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offers under Rules 14d-2(b) or 13e-4(c) at this time.
  • Emerging Growth Company Status: Dominari Holdings Inc. is not classified as an emerging growth company, which may affect its regulatory obligations and investor expectations.

Other Notable Corporate Details

  • Company Details: The company is incorporated in Delaware and its principal executive offices are located at 725 5th Avenue, 22nd Floor, New York, NY.
  • Stock Exchange Information: Dominari Holdings Inc.’s common stock, with a par value of \$0.0001 per share, trades under the symbol DOMH on the Nasdaq Capital Market.
  • CEO Signature: The report was signed by Anthony Hayes, Chief Executive Officer, on March 5, 2026, confirming the authenticity of the actions and resolutions reported.

Summary for Investors

The amendments to the equity incentive plan represent a substantial change in the company’s capital structure, directly affecting the number of shares available for employee and executive incentives. Such moves are typically watched closely by investors, as they can impact dilution, talent retention, and future growth. The approval of these proposals by shareholders signals confidence in management’s strategy, but also warrants attention to future company actions related to share issuance and compensation.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should consult their financial advisors and review the original SEC filings before making any investment decisions. The information provided is based on the latest available filings and may be subject to change.

View Dominari Holdings Inc. Historical chart here



Acadia Pharmaceuticals Inc. Files Form 8-K with SEC: Company Information, Stock Details, and Filing Summary (March 2026)

Acadia Pharmaceuticals Inc. Announces Director Appointment and Equity Compensation Details Acadia Pharmaceuticals Inc. Announces Appointment of New Director and Equity Compensation Changes San Diego, CA (March 3, 2026) — Acadia Pharmaceuticals Inc. (NASDAQ: ACAD),...

Invest Green Acquisition Corporation 8-K Filing: Company Details, Security Information, and XBRL Data (Feb 17, 2026)

Invest Green Acquisition Corporation Issues \$3,500,000 Unsecured Promissory Note to Sponsor Key Developments: On February 17, 2026, Invest Green Acquisition Corporation (“the Company”) announced it has issued an unsecured promissory note in the aggregate...

MarineMax Announces New $100 Million Stock Repurchase Plan Through March 2028

MarineMax Announces New \$100 Million Share Repurchase Plan MarineMax, Inc. Launches New \$100 Million Stock Repurchase Plan, Replaces Previous Program Key Highlights for Investors MarineMax, Inc. (NYSE: HZO) Board Approves New Share Buyback Plan:...

   Ad